A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But ...

He pointed to Boehringer Ingelheim’s decision to drop list prices on Spiriva HandiHaler, an older inhaler that now faces generic competition, and not its newer product, Spiriva Respimat.

German drugmaker Boehringer Ingelheim was accused in a federal lawsuit in Boston on Wednesday of improperly submitting patents to the U.S. Food and Drug Administration to delay generic competition ...

Spiriva HandiHaler is available as the generic drug tiotropium powder for inhalation. To find out how the costs of the brand-name and generic versions compare, talk with your doctor, pharmacist ...

Spiriva is a prescription drug that's used to treat asthma and COPD. Learn about its possible interactions with other drugs, alcohol, and more.

Spiriva HandiHaler was approved by the FDA in 2004 as a COPD maintenance treatment and in 2009 to reduce COPD exacerbations. Like the approved generic, it is not intended as a rescue medication for ...

Lupin has received the Food and Drug Administration’s permission for Tiotropium Bromide Inhalation Powder, 18 mcg/capsule, which is a generic of Boehringer Ingelheim’s Spiriva HandiHaler.

The newly approved tiotropium bromide capsules manufactured by Lupin are a generic version of the Spiriva HandiHaler (Boehringer Ingelheim Pharmaceuticals Inc.), according to the release.

Spiriva took another sales slide as it began to face generic competition in Europe in 2021. It still recorded (PDF) sales of $1.7 billion last year, with $1.3 billion coming in the U.S.

Lupin gets US FDA approval for key respiratory drug Spiriva generic; stock jumps over 5% This product will be manufactured at Lupin’s Pithampur facility in India J Jagannath ...